Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 31, 2022
Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening TrialUgo Pastorino, Vito Ladisa, Sara Trussardo, et al.Tumori|October 28, 2024
Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjectsOscar Illescas, Antonino Belfiore, Luca Varinelli, et al.International Journal of Environmental Research and Public Health|March 11, 2023
Multidimensional Results and Reflections on CAR-T: The Italian EvidenceEmanuela Foglia, Elisabetta Garagiola, Vito Ladisa, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 6, 2026
Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP TrialMassimiliano Cani, Daniela Bafunno, Francesca Caumo, et al.Tumori|May 5, 2020
Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di MilanoFranco Valenza, Gabriele Papagni, Alfonso Marchianò, et al.Frontiers in Pharmacology|March 25, 2026
Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European regionJulie Vancoppenolle, Nora Franzen, Cristina Andrianò, et al.Theranostics|October 21, 2024
Preclinical pharmacology of patient-derived extracellular vesicles for the intraoperative imaging of tumorsAlessandro Villa, Daniela Crescenti, Zemira De Mitri, et al.Frontiers in Oncology|April 11, 2024
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)Alessandro Cafaro, Flavia Foca, Oriana Nanni, et al.JCO Precision Oncology|July 24, 2023
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient CareAndrea Vingiani, Luca Agnelli, Matteo Duca, et al.Cancers|May 25, 2024
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study)Alessandro Cafaro, Flavia Foca, Oriana Nanni, et al.Pageof 2